Nalaganje...
Prognostication with circulating tumor DNA: is it ready for prime time?
Emerging methods to detect tumor-derived DNA in the blood plasma of patients with lymphomas—so-called “circulating tumor DNA” (ctDNA)—have the potential to change the way in which lymphoma is diagnosed and managed in the clinic. The possible applications for ctDNA are numerous, including mutation ge...
Shranjeno v:
| izdano v: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913479/ https://ncbi.nlm.nih.gov/pubmed/31808836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000013 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|